Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction.  Our approach will be generally applicable across a range of inflammatory diseases including peripheral indications.   The current therapeutic target is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation.  

Biotechnology

Health Care

Therini Bio, Inc.

Therini Bio, Inc.'s headquarters in San Francisco, CA, United States

Therini Bio, Inc.

Org chart

Teams

Offices

Similar companies